LEVILIMAB

UNII: P7UV3L2H80
Preferred Substance Name: LEVILIMAB

2035008-70-7
BCD-089
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN MONOCLONAL BCD-089 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BCD-089 .KAPPA.-CHAIN, DIMER
LEVILIMAB [INN]
LEVILIMAB [WHO-DD]

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

LEVILIMAB

Synonyms and Mappings

Resources

Note